Renalytix plc (RNLXY) stock
RNLXYOTCServices-Medical LaboratoriesFiscal year ends June 30Also trades as RENXF
Financials through Q1 FY2025, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$3.56+0.06 (+1.57%)
Close on Oct 19, 2026Market cap $375.75MP/E –Yield –
Renalytix price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Renalytix's price to sales ratio was 250.8× on Oct 19, 2026.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 250.8× | −4.6 |
| 2025 | Dec 31, 2025 | 255.4× | – |
See a number that looks wrong?